Conferences

The third Conference Cancer Stem Cells (CSCs): Impact on Treatment - 2020 will be devoted to the problems of primary and acquired therapy resistances associated with disease progression and poor clinical outcomes in cancer patients. It is planned that pre-clinical and clinical sessions will be included into the program of the conference. The leading basic researchers, translational researchers and clinicians will be invited to provide a number of educational lectures and to serve as chairs of the Symposium Sessions.

This Conference will highlight following CSC-related problems: 

• signaling pathways contributing to the treatment resistance and disease progression;
• role of CSCs in the treatment failure;
• molecular mechanisms associated with CSC aggressiveness and increased metastatic potential;
• CSC metabolism;
• circadian rhythms in CSCs and metronomic chemotherapy;
• crosstalk between CSCs and microenvironmental factors (tumor stroma, immune system);
• biological, biochemical, pathological methods allowing CSC identification within the malignant tumors;
• pediatric tumors and CSCs;
• epigenetic factors in CSC formation;
• glioblastoma stem cells;
• development of novel biomarkers and therapeutic targets to predict and overcome therapy resistance associated with CSC activities;
• novel therapeutic approaches to combat locally advanced, metastatic or relapsed malignant diseases;
• chemical agents against CSCs;
• translational oncology: how to make bridge between basic researchers and clinicians;
• clinical trials based on pre-clinical findings

https://www.csc-conference.at/about-conference/